An amphiphilic hyaluronic acid (HA)-based lipoid (HA-ACVA-AZ) was prepared as the shell of nanobullets to provide dual-targeting effect for nanobullets toward hypoxic tumor cells overexpressing cluster determinant 44 (CD44) receptors and CA IX. Here, CA9 is linked to neoplasm.